Mueller-Sarnowski, Felix
Sollmann, Nico
Schröder, Axel
Houri, Leen
Ille, Sebastian
Grimmer, Timo
Krieg, Sandro M.
Diehl-Schmid, Janine http://orcid.org/0000-0002-7745-1382
Funding for this research was provided by:
Technische Universität München
Article History
Accepted: 15 November 2021
First Online: 28 December 2021
Declarations
:
: The study was approved by the local ethics committee (#377/18 S) and conducted in line with the principles expressed in the Declaration of Helsinki.
: Each participant provided written informed consent prior to enrollment.
: Not applicable.
: Felix Müller-Sarnowski, Timo Grimmer and Janine Diehl-Schmid have no competing interests with regard to the submitted manuscript. Outside the submitted manuscript TG received consulting fees from Abbvie, Anavex, Biogen, Bracket, Eli Lilly, Functional Neuromodulation, Iqvia/Quintiles, Novartis, Novo Nordisk, NuiCare, Roche Pharma, Toyama, and Vivoryon; lecture fees from Actelion, B.Braun, Biogen, Eli Lilly, Life Molecular Imaging, Novartis, Parexel, and Roche Pharma; and grants to his institution from Actelion and Novartis. Sandro Krieg is consultant for Ulrich Medical (Ulm, Germany) and received honoraria from Nexstim Plc (Helsinki, Finland), Spineart Deutschland GmbH (Frankfurt, Germany), Medtronic (Meerbusch, Germany) and Carl Zeiss Meditec (Oberkochen, Germany). Sandro Krieg and Sebastian Ille are consultants for Brainlab AG (Munich, Germany). Sebastian Ille and Nico Sollmann received honoraria from Nexstim Plc (Helsinki, Finland).